Literature DB >> 25844412

[Misuse and abuse of quetiapine].

Agnieszka Piróg-Balcerzak1, Bogusław Habrat2, Paweł Mierzejewski3.   

Abstract

Quetiapine is an atypical antipsychotic agent, frequently used in psychiatry, often for symptomatic treatment against a number of mental disorders differing from the registration indications. One of the use is to soothe the clinical conditions caused by the use of various psychoactive substances. The paper presents and discusses the reports of quetiapine misuse, abuse, and even mental addiction, as well as symptoms similar to the so-called discontinuation syndrome, often mixed with withdrawal syndrome occurring in the course of addiction. Most reports concern males, and especially those with a history of other psychoactive substance abuse, and personality disorders, often in conflict with the law. Therefore, clinicians should be cautious when prescribing quetiapine to such patients. The article discusses potential mechanisms responsible for quetiapine abuse. This is probably related to its sedative and anxiolytic activity which results in the frequent use with stimulants. Also, high affinity for the H1 receptor, as antihistamines agents causes rewarding action.

Entities:  

Keywords:  abuse; addiction; quetiapine

Mesh:

Substances:

Year:  2015        PMID: 25844412     DOI: 10.12740/PP/32923

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  3 in total

1.  The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015.

Authors:  Pål Gjerden; Jørgen G Bramness; Ingunn Fride Tvete; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2017-06-16       Impact factor: 2.953

2.  Acute Extrapyramidal Side Effects from Smoked Haloperidol.

Authors:  Angeline Pham; Joo-Young Lee; Christopher W T Miller
Journal:  Case Rep Psychiatry       Date:  2021-10-02

Review 3.  Multi-Target Approach for Drug Discovery against Schizophrenia.

Authors:  Magda Kondej; Piotr Stępnicki; Agnieszka A Kaczor
Journal:  Int J Mol Sci       Date:  2018-10-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.